Filitra 10mg Action Mechanism
Filitra 10 mg works by using its active ingredient, vardenafil, a PDE5 (phosphodiesterase type 5) inhibitor, to treat erectile dysfunction (ED). It enhances blood flow to the penis, enabling men to achieve and maintain an erection during sexual stimulation.
Inhibition of PDE5 Enzyme
PDE5 (phosphodiesterase type 5) is an enzyme that breaks down cyclic guanosine monophosphate (cGMP), essential for relaxing blood vessels. Vardenafil inhibits PDE5, preventing the breakdown of cGMP and allowing it to accumulate in the penile tissues.
Relaxation of Smooth Muscles
Increased levels of cGMP relax the smooth muscles in the walls of blood vessels in the penis. It leads to vasodilation (widening of blood vessels), enhancing blood flow in the erectile tissues (corpus cavernosum) on both sides of the penis.
Improved Blood Flow
With relaxed blood vessels and increased blood flow, the corpora cavernosa (spongy tissues in the penis) fills with blood more easily during arousal.
Erection during Sexual Stimulation
The enhanced blood flow enables a firm and sustainable erection when sexually aroused. Sexual stimulation is necessary for Filitra to work-it does not cause an automatic erection.
Filitra 10 mg begins within 15-30 minutes after ingestion, making it suitable for spontaneous use. The effects last for 4-6 hours, giving users a wide window of opportunity for sexual activity.
Selective Targeting
Vardenafil selectively targets PDE5, minimizing side effects in other body parts (e.g., the retina, reducing visual disturbances compared to sildenafil).
Improved Response with Lower Dose
As a potent PDE5 inhibitor, vardenafil achieves significant results even at lower doses like 10 mg.
How It Supports Erectile Function
Filitra enhances the natural erectile process. It helps overcome the physical challenges of ED by improving vascular health and blood flow.